Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuxintong capsule for exercise tolerance in stable coronary artery disease
ChiCTR2000041293Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Dec 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yuxintong in coronary arteriosclerosis (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Peak VO2 and Anaerobic threshold. Started Dec 2019; status: recruiting.
02
Drugs
Yuxintong
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000041293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041293.